Archives

Generium Launches First Biosimilar of Eculizumab; Becomes Fifth Marketed Product Using Selexis SUREtechnology Platform

Selexis Earns Spot Among the “Best Workplaces in Switzerland” for Second Consecutive Year

Selexis Bolsters Business Development Team to Support Expanding Base of Partners Relying on Its SUREtechnology to Advance Complex Biologics and Vaccines

Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements

Selexis Expands Strategic Immuno-Oncology Alliance with Agenus